BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23848574)

  • 1. Case report: Physical therapy management of axial dystonia.
    Voos MC; Oliveira Tde P; Piemonte ME; Barbosa ER
    Physiother Theory Pract; 2014 Jan; 30(1):56-61. PubMed ID: 23848574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiotherapy in cervical dystonia: six experimental single-case studies.
    Zetterberg L; Halvorsen K; Färnstrand C; Aquilonius SM; Lindmark B
    Physiother Theory Pract; 2008; 24(4):275-90. PubMed ID: 18574753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia.
    Hu W; Rundle-Gonzalez V; Kulkarni SJ; Martinez-Ramirez D; Almeida L; Okun MS; Wagle Shukla A
    Parkinsonism Relat Disord; 2019 Jun; 63():195-198. PubMed ID: 30837195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.
    Lew MF; Adornato BT; Duane DD; Dykstra DD; Factor SA; Massey JM; Brin MF; Jankovic J; Rodnitzky RL; Singer C; Swenson MR; Tarsy D; Murray JJ; Koller M; Wallace JD
    Neurology; 1997 Sep; 49(3):701-7. PubMed ID: 9305326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance.
    Samotus O; Lee J; Jog M
    J Neurol; 2018 Jun; 265(6):1269-1278. PubMed ID: 29557988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin.
    Tarsy D
    Mov Disord; 1997 Jan; 12(1):100-2. PubMed ID: 8990061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale.
    Comella CL; Stebbins GT; Goetz CG; Chmura TA; Bressman SB; Lang AE
    Mov Disord; 1997 Jul; 12(4):570-5. PubMed ID: 9251076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inter-rater reliability while using the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) in patients with cervical dystonia].
    Kaji R; Osawa M; Yanagisawa N
    Brain Nerve; 2009 Jan; 61(1):65-71. PubMed ID: 19177808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia.
    Comella CL; Jankovic J; Shannon KM; Tsui J; Swenson M; Leurgans S; Fan W;
    Neurology; 2005 Nov; 65(9):1423-9. PubMed ID: 16275831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensorimotor Perceptive Rehabilitation Integrated (SPRInt) program: exercises with augmented movement feedback associated to botulinum neurotoxin in idiopathic cervical dystonia-an observational study.
    Castagna A; Caronni A; Crippa A; Sciumè L; Giacobbi G; Corrini C; Montesano A; Ramella M
    Neurol Sci; 2020 Jan; 41(1):131-138. PubMed ID: 31478151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy of deep brain stimulation in the surgical treatment of cervical dystonia.
    Calheiros-Trigo F; Linhares P
    Neurocirugia (Astur); 2014; 25(2):49-55. PubMed ID: 24630435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia.
    Münchau A; Palmer JD; Dressler D; O'Sullivan JD; Tsang KL; Jahanshahi M; Quinn NP; Lees AJ; Bhatia KP
    Brain; 2001 Apr; 124(Pt 4):769-83. PubMed ID: 11287376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of treatment strategies for muscle function in infants with congenital muscular torticollis.
    Ohman A; Mårdbrink EL; Stensby J; Beckung E
    Physiother Theory Pract; 2011 Oct; 27(7):463-70. PubMed ID: 21568831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postural rehabilitation and Kinesio taping for axial postural disorders in Parkinson's disease.
    Capecci M; Serpicelli C; Fiorentini L; Censi G; Ferretti M; Orni C; Renzi R; Provinciali L; Ceravolo MG
    Arch Phys Med Rehabil; 2014 Jun; 95(6):1067-75. PubMed ID: 24508531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical dystonia: disease profile and clinical management.
    Crowner BE
    Phys Ther; 2007 Nov; 87(11):1511-26. PubMed ID: 17878433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse sensory geste in cervical dystonia.
    Asmus F; von Coelln R; Boertlein A; Gasser T; Mueller J
    Mov Disord; 2009 Jan; 24(2):297-300. PubMed ID: 19086084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KinesioTaping after botulinum toxin type A for cervical dystonia in adult patients.
    Dec-Ćwiek M; Porębska K; Sawczyńska K; Kubala M; Witkowska M; Zmijewska K; Antczak J; Pera J
    Brain Behav; 2022 Apr; 12(4):e2541. PubMed ID: 35238494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.